MPROTECTION Trademark

Trademark Overview


On Friday, July 1, 2022, a trademark application was filed for MPROTECTION with the United States Patent and Trademark Office. The USPTO has given the MPROTECTION trademark a serial number of 97486088. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 1, 2024. This trademark is owned by ModernaTx, Inc.. The MPROTECTION trademark is filed in the Chemical Products, Pharmaceutical Products, and Computer & Software Services & Scientific Services categories with the following description:

vaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological, and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations, all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid...

lipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders

Pharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines
mprotection

General Information


Serial Number97486088
Word MarkMPROTECTION
Filing DateFriday, July 1, 2022
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 1, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 4, 2023

Trademark Statements


Goods and Servicesvaccines; vaccine adjuvants; medical, biological, and pharmaceutical preparations for medical use, namely, medical, biological, and pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; mRNA-based therapeutics in the nature of therapeutic agents and therapeutic agents for use in vivo, ex vivo, or in situ for the prevention and treatment of viruses rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, and respiratory disorders; lipid nanoparticles for use as drug delivery carriers sold as an integral component of pharmaceutical preparations, all for pharmaceutical, medical or medical diagnostic purposes; drug carriers for medical use, namely, drug delivery agents consisting of lipid nanoparticles that facilitate delivery of pharmaceuticals; pharmaceutical preparations, namely, messenger RNA (mRNA) therapeutic agents and delivery agents comprised of lipid nanoparticle carriers and polymers for the delivery of mRNA to human cells
Pseudo MarkM PROTECTION
Goods and Serviceslipid nanoparticles for use in the manufacture of pharmaceuticals, namely, for use in the manufacture of pharmaceutical preparations containing messenger RNA (mRNA) for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, and metabolic disorders; biochemicals for medical research for use in the manufacture of pharmaceuticals for preventing and treating viruses, respiratory disorders, rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders
Goods and ServicesPharmaceutical research and development; medical research services; biotechnology research; scientific research for medical purposes; design and development of medical technology; design, engineering, research, and development services in the field of nucleic acid sciences for medical and scientific applications; providing medical and scientific research in the fields of pharmaceuticals and vaccines

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateThursday, July 21, 2022
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 21, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 21, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameModernaTx, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressCambridge, MA 02142

Party NameModernaTx, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressCambridge, MA 02139

Trademark Events


Event DateEvent Description
Monday, April 1, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 1, 2024ABANDONMENT - NO USE STATEMENT FILED
Sunday, March 31, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, March 31, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, March 31, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, March 31, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, March 31, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, August 30, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, August 30, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, August 30, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, August 30, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, August 30, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, August 29, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 10, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 10, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 10, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, August 10, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, August 10, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, July 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 4, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 14, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, May 31, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, May 5, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, April 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NON-FINAL ACTION E-MAILED
Tuesday, April 18, 2023NON-FINAL ACTION WRITTEN
Monday, April 17, 2023ASSIGNED TO EXAMINER
Thursday, July 21, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, July 5, 2022NEW APPLICATION ENTERED